Clinical trial

Neurofilaments for NEDA Assessing in MS

NCT03250169

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2017-08-01

PhaseN/A

Study timeline

Study start (actual)2017-08-01Date precision: day

Registry last updated2022-02-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

AlemtuzumabDRUG · verified · RxNorm: alemtuzumab

Sponsors & collaborators

Queen Mary University of Londonlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03250169 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.